secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2026-08-12T20:56:09+00:00
Accession:  0001213900-26-088435
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies raises $5M initial tranche via convertible notes and warrants
--------------------------------------------------------------------------

- Closed initial $5M tranche of private placement; issued $5.405M principal in 9% senior secured convertible notes.
- Notes convertible at $2.05/share; 600k shares, 900k pre-funded warrants, 1.5M warrants issued at closing.
- $2.2M bridge note converted into $2.378M note plus warrants; notes mature in 9 months, prepayable at 110%.
- Second $5M tranche optional; placement agent Ceros gets 5% cash fee and 75k warrants at $3.14.
- Proceeds for clinical development and working capital; company barred from dividends without holder consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026088435/0001213900-26-088435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026088435/ea0301485-8k_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-088435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer